APA (7th ed.) Citation

Moorman, A., Robinson, H., Schwab, C., Richards, S., Hancock, J., Mitchell, C., . . . Harrison, C. (2013). Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: A comparison of the MRC ALL97/99 and UKALL2003 trials.

Chicago Style (17th ed.) Citation

Moorman, A., H. Robinson, C. Schwab, S. Richards, J. Hancock, C. Mitchell, N. Goulden, A. Vora, and C. Harrison. Risk-directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents with Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials. 2013.

MLA (9th ed.) Citation

Moorman, A., et al. Risk-directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents with Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials. 2013.